Abstract:Introduction: Retinopathy of prematurity (ROP) is a retinal vascular developmental disease associated with risks factors such as supplementary oxygen use or low birth weight/early gestational age. Multiple studies have reported associations between ROP and systemic inflammation. In this study, we investigated serum cytokines associated with ROP development and severity and assessed their applicability as potential biomarkers of ROP. Methods: This prospective study was conducted at an institutional referral center between 2019 and 2021. To measure the serum levels of 40 inflammatory cytokines in eligible premature patients, we collected their serum samples during the enrollment of patients or the intravitreal injection of anti–vascular endothelial growth factor (VEGF) agents and after 2 and 4 weeks. Results: Fifty patients were enrolled. In patients with type 1 ROP who received anti-VEGF agents ( n = 22), the levels of serum intercellular adhesion molecule-1 decreased significantly ( p < 0.05) at 4 weeks compared with the baseline level, whereas those of serum granulocyte–macrophage colony-stimulating factor increased significantly ( p < 0.05). In patients with ROP who did not require any treatment ( n = 14), no significant change was noted in the level of any of the 40 inflammatory cytokines. In control infants without ROP ( n = 14), the serum levels of tumor necrosis factor-α, interleukin (IL)-15, and IL-12p40 increased significantly ( p < 0.05) at 4 weeks. The changes in the levels of serum inflammatory cytokines did not vary significantly among the aforementioned three groups. A generalized estimating equation indicated that zone 1 ROP, stage 3 ROP, older postmenstrual age, respiratory distress syndrome, necrotizing enterocolitis, and sepsis were associated with the changes in serum cytokine levels. Conclusions: Although significant changes (compared with baseline) were observed in the serum levels of certain inflammatory cytokines in patients with type 1 ROP and infants without ROP, no significant difference in cytokine level fluctuations were noted among the three groups. Changes in serum inflammatory cytokine levels may not predict ROP development or severity. Additional comprehensive studies are warranted to establish their definitive role and significance in ROP, emphasizing the need for continued research in this area.

Arachidonic acid metabolism regulates the development of retinopathy of prematurity among preterm infants

Maternal Omega-3 PUFA Supplementation Prevents Hyperoxia-Induced Pulmonary Hypertension in the Offspring

Plasma Levels of Amino Acids and Derivatives in Retinopathy of Prematurity.

Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity

Arachidonic acid and docosahexaenoic acid levels correlate with the inflammation proteome in extremely preterm infants

Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants

Retinopathy of prematurity: A review of pathophysiology and signaling pathways

Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity

A Prospective Analysis of the Retinopathy of Prematurity Correlated with the Inflammatory Status of the Extremely Premature and Very Premature Neonates

Nutritional interventions to prevent retinopathy of prematurity

Retinopathy of prematurity: contribution of inflammatory and genetic factors

Effect of Optimizing Oxygen Saturation Targets on the Incidence of Retinopathy of Prematurity in a Quaternary NICU

Retinopathy of Prematurity—Targeting Hypoxic and Redox Signaling Pathways

Loss of 15-Lipoxygenase in Retinodegenerative RCS Rats

Photoreceptor glucose metabolism determines normal retinal vascular growth

The Effect of STAT3 Signal Pathway Activation on Retinopathy of Prematurity.

Association of serum levels of inflammatory cytokines with retinopathy of prematurity in preterm infants

Targeting adenosine A2A receptors for early intervention of retinopathy of prematurity

Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies

Strategies to Prevent Severe Retinopathy of Prematurity: A 2020 Update and Meta-analysis

Beyond Fetal Immunity: A Systematic Review and Meta-Analysis of the Association Between Antenatal Corticosteroids and Retinopathy of Prematurity